Journal ArticleOPEN ACCESS

Treatment of Relapsed/Refractory Multiple Myeloma with Ciltacabtagene Autoleucel or Idecabtagene Vicleucel in Racial Minorities-a Multicenter Study

  • Chang D
  • Habib A
  • Vegel A
  • et al.
Blood (2024) 144(Supplement 1) 2404-2404
DOI: 10.1182/blood-2024-208692
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Chang, D., Habib, A., Vegel, A., Struble, E., Shaikh, H., Strouse, C., … Bhutani, M. (2024). Treatment of Relapsed/Refractory Multiple Myeloma with Ciltacabtagene Autoleucel or Idecabtagene Vicleucel in Racial Minorities-a Multicenter Study. Blood, 144(Supplement 1), 2404–2404. https://doi.org/10.1182/blood-2024-208692

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free